StockData
Senti Biosciences Holdings, Inc. logo

Senti Biosciences Holdings, Inc. (SNTI) stock

SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.10−0.04 (-28.68%)

Close on Nov 17, 2026Market cap $3.02MP/E –Yield –

Senti Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Senti Biosciences's price to book ratio was 4.1× on Jul 31, 2026, against 1.2× a year earlier. Over the last 4 years it ranged from 0.1× to 13.4×, with a median of 0.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20264.1×+0.8
2025Dec 31, 20253.4×+2.4
2024Dec 31, 20241.0×+0.7
2023Dec 29, 20230.4×−0.1
2022Dec 30, 20220.4×–

More Senti Biosciences figures

See a number that looks wrong?